The Pathophysiology of Immune-mediated Heparin-induced Thrombocytopenia

Seminars in Dialysis

Volumn 16, Issue 1, 2003, Pages 54-60

  Reilly, Robert F ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; HEPARIN; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G; PROCOAGULANT; THROMBOCYTE FACTOR 4; THROMBOPLASTIN; ANTICOAGULANT AGENT;

ANTIBODY RESPONSE; ANTIGEN ANTIBODY COMPLEX; BIOASSAY; CELL DAMAGE; CELL SECRETION; CLINICAL FEATURE; COMPLEX FORMATION; DIAGNOSTIC PROCEDURE; DRUG BINDING; EPIDEMIOLOGICAL DATA; FUNCTION TEST; HEPARINIZATION; HUMAN; IMMUNE RESPONSE; MONOCYTE; MORBIDITY; MORTALITY; PATHOPHYSIOLOGY; PROTEIN DOMAIN; PROTEIN SECRETION; REVIEW; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOSIS; CHEMICALLY INDUCED DISORDER; DIFFERENTIAL DIAGNOSIS; IMMUNOLOGY; RENAL REPLACEMENT THERAPY; RISK FACTOR;

ANTICOAGULANTS; DIAGNOSIS, DIFFERENTIAL; HEPARIN; HUMANS; RENAL DIALYSIS; RISK FACTORS; THROMBOCYTOPENIA;

EID: 0038657918     PISSN: 08940959     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-139X.2003.03013.x     Document Type: Review

References (60)

1. Warkentin TE, Chong BH, Greinacher A: Heparin-induced thrombocytopenia: towards consensus. Thromb Haemost 79:1-7, 1998
2. Weismann RE, Tobin RW: Arterial embolism occurring during systemic heparin therapy. Arch Surg 76:219-227, 1958
3. Rhodes GR, Dixon RH, Silver D: Heparin induced thrombocytopenia with thrombotic and hemorrhagic manifestations. Surg Gynecol Obstet 136:409-416, 1973
4. Amiral J, Bridey F, Dreyfus M, Vissoc AM, Fressinaud E, Wolf M, Meyer D: Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost 68:95-96, 1992
5. Warkentin TE: Clinical presentation of heparin-induced thrombocytopenia. Semin Hematol 35(suppl 4):9-16, 1998
6. Kelton JG: Heparin-induced thrombocytopenia: an overview. Blood Rev 16:77-80, 2002
7. Baglin TP: Heparin induced thrombocytopenia thrombosis (HIT/T) syndrome: diagnosis and treatment. J Clin Pathol 54:272-274, 2001
8. Fabris F, Ahmad S, Cella G, Jeske WP, Walenga JM, Fareed J: Pathophysiology of heparin-induced thrombocytopenia. Clinical and diagnostic implications - a review. Arch Pathol Lab Med 124:1657-1666, 2000
9. Warkentin TE: Heparin-induced thrombocytopenia: a clinicopathologic syndrome. Thromb Haemost 82:439-447, 1999
10. Hach-Wunderle V, Kainer K, Krug B, Muller-Berghaus G, Potzsch B: Heparin-associated thrombosis despite normal platelet counts. Lancet 344:469-470, 1994
11. Derek JK, Kelton JG: Heparin-associated thrombocytopenia. Ann Intern Med 100:535-540, 1984
12. Schmitt BP, Adelman B: Heparin-associated thrombocytopenia: a critical review and pooled analysis. Am J Med Sci 305:208-215, 1993
13. Lee DP, Warkentin TE: Frequency of heparin-induced thrombocytopenia. In: Warkentin TE, Greinacher A (eds). Heparin-induced Thrombocytopenia, 2nd ed. New York: Marcel Decker, 2001
14. Warkentin TE, Levine MN, Hirsh J, Horsewood P, Roberts RS, Gent M, Kelton JG: Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 332:1330-1335, 1995
15. Warkentin TE, Sheppard JA, Horsewood P, Simpson PJ, Moore JC, Kelton JG: Impact of the patient population on the risk for heparin-induced thrombocytopenia. Blood 96:1703-1708, 2000
16. Yamamoto S, Koide M, Matsuo M, Suzuki S, Ohtaka M, Saika S, Matsuo T: Heparin-induced thrombocytopenia in hemodialysis patients. Am J Kidney Dis 28:82-85, 1996
17. Greinacher A, Zinn S, Wizemann, Birk UW: Heparin-induced antibodies as a risk factor for thromboembolism and haemorrhage in patients undergoing chronic haemodialysis [letter]. Lancet 348:764, 1996
18. Sitter T, Spannagl M, Banas B, Schiffl H: Prevalence of heparin-induced PF4-heparin antibodies in hemodialysis patients. Nephron 79:245-246, 1998
19. Luzzatto G, Bertoli M, Cella G, Fabris F, Zaia B, Girolami A: Platelet count, anti-heparin/platelet factor 4 antibodies and tissue factor pathway inhibitor plasma antigen level in chronic dialysis. Thromb Res 89:115-122, 1998
20. Boon DM, van Vliet HH, Zietse R, Kappers-Klunne MC: The presence of antibodies against a PF4-heparin complex in patients on haemodialysis. Thromb Haemost 76:480, 1996
21. O'Shea SI, Sands JJ, Nudo SA, Ortel TL: Frequency of anti-heparin- platelet factor 4 antibodies in hemodialysis patients and correlation with recurrent vascular access thrombosis. Am J Hematol 69:72-73, 2002
22. Warkentin TE, Kelton JG: Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med 344:1286-1292, 2001
23. Warkentin TE, Kelton JG: Delayed-onset heparin-induced thrombocytopenia and thrombosis. Ann Intern Med 135:502-506, 2001
24. Rice L, Attisha WK, Drexler A, Francis JL: Delayed-onset heparin-induced thrombocytopenia. Ann Intern Med 136:210-215, 2002
25. Boshkov LK, Warkentin TE, Hayward CP, Andrew M, Kelton JG: Heparin-induced thrombocytopenia and thrombosis: clinical and laboratory studies. Br J Haematol 84:322-328, 1993
26. Greinacher A, Amiral J, Dummel V, Vissac A, Kiefel V, Mueller-Eckhardt C: Laboratory diagnosis of heparin-associated thrombocytopenia and comparison of platelet aggregation test, heparin-induced platelet activation test, and platelet factor 4/heparin enzyme-linked immunosorbent assay. Transfusion 34:381-385, 1994
27. Elalamy I, Lecrubier C, Horellou MH, Conard J, Samama MM: Heparin-induced thrombocytopenia: laboratory diagnosis and management. Ann Med 32(suppl 1):60-67, 2000
28. Sheridan D, Carter C, Kelton JG: A diagnostic test for heparin-induced thrombocytopenia. Blood 67:27-30, 1986
29. Chong BH, Burgess J, Ismail F: The clinical usefulness of the platelet aggregation test for the diagnosis of heparin-induced thrombocytopenia. Thromb Haemost 69:344-350, 1993
30. Arepally G, Reynolds C, Tomaski A, Amiral J, Jawad A, Poncz M, Cines DB: Comparison of PF4/heparin ELISA assay with the 14C-serotonin release assay in the diagnosis of heparin-induced thrombocytopenia. Am J Clin Pathol 104:648-654, 1995
31. Look KA, Sahud M, Flaherty S, Zehnder JL: Heparin-induced platelet aggregation vs platelet factor 4 enzyme-linked immunosorbent assay in the diagnosis of heparin-induced thrombocytopenia-thrombosis. Am J Clin Pathol 108:78-82, 1997
32. Harenberg J, Wang L, Hoffmann U, Huhle G, Feuring M: Improved laboratory confirmation of heparin-induced thrombocytopenia type 11. Time course of antibodies and combination of antigen and biologic assays. Am J Clin Pathol 115:432-438, 2001
33. Amiral J, Wolf M, Fischer A, Boyer-Neumann C, Vissac A, Meyer D: Pathogenicity of IgA and/or IgM antibodies to heparin-PF4 complexes in patients with heparin-induced thrombocytopenia. Br J Haematol 92:954-959, 1996
34. Suh JS, Malik MI, Aster RH, Visentin GP: Characterization of the humoral immune response in heparin-induced thrombocytopenia. Am J Hematol 54:196-201, 1997
35. Nguyen P, Droulle C, Potron G: Comparison between platelet factor 4/heparin complexes ELISA and platelet aggregation test in heparin-induced thrombocytopenia. Thromb Haemost 74:804-805, 1995
36. Lindhoff-Last E, Gerdsen F, Ackermann H, Bauersachs R: Determination of heparin-platelet factor 4-IgG antibodies improves diagnosis of heparin-induced thrombocytopenia. Br J Haematol 113:886-890, 2001
37. Kelton JG, Sheridan D, Santos A, Smith J, Sleeves K, Smith C, Brown C, Murphy WG: Heparin-induced thrombocytopenia: laboratory studies. Blood 72:925-930, 1988
38. Anderson GP: Insights inlo heparin-induced thrombocytopenia. Br J Haematol 80:504-508, 1992
39. Visentin GP, Ford SE, Scott JP, Aster RH: Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. J Clin Invest 93:81-88, 1994
40. Kelton JG, Smith JW, Warkentin TE, Hayward CP, Denomme GA, Horsewood P: Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4. Blood 83:3232-3239, 1994
41. Home MK III, Alkins BR: Platelet binding of IgG from patients with heparin-induced thrombocytopenia. J Lab Clin Med 127:435-442, 1996
42. Newman PM, Chong BH: Heparin-induced thrombocytopenia: new evidence for the dynamic binding of purified anti-PF4-heparin antibodies to platelets and the resultant platelet activation. Blood 96:182-187, 2000
43. Gewirtz AM, Calabretta B, Rucinski B, Niewiarowski S, Xu WY: Inhibition of human megakaryocytopoiesis in vitro by platelet factor 4 (PF4) and a synthetic COOH-terminal PF4 peptide. J Clin Invest 83:1477-1486, 1989
44. Maione TE, Gray GS, Petro J, Hunt AJ, Donner AL, Bauer SI, Carson HF, Sharpe RJ: Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science 247:77-79, 1990
45. Sharpe RJ, Byers HR, Scott CF, Bauer SI, Maione TE: Growth inhibition of murine melanoma and human colon carcinoma by recombinant human platelet factor 4. J Natl Cancer Inst 82:848-853, 1990
46. Sato Y, Abe M, Takaki R: Platelet factor 4 blocks the binding of basic fibroblast growth factor to the receptor and inhibits the spontaneous migration of vascular endothelial cells. Biochem Biophys Res Commun 172:595-600, 1990
47. Poncz M, Surrey S, LaRocco P, Weiss MJ, Rappaport EF, Conway TM, Schwartz E: Cloning and characterization of platelet factor 4 cDNA derived from a human erythroleukemic cell line. Blood 69:219-223, 1987
48. St. Charles R, Walz DA, Edwards BF: The three-dimensional structure of bovine platelet factor 4 at 3.0-A resolution. J Biol Chem 264:2092-2099, 1989
49. Barber AJ, Kaser-Glanzmann R, Jakabova M, Luscher EF: Characterization of a chondroitin 4-sulfate proteoglycan carrier for heparin neutralizing activity (platelet factor 4) released from human blood platelets. Biochim Biophys Acta 286:312-329, 1972
50. Horsewood P, Warkentin TE, Hayward CP, Kelton JG: The epitope specificity of heparin-induced thrombocytopenia. Br J Haematol 95:161-167, 1996
51. Suh JS, Aster RH, Visentin GP: Antibodies from patients with heparin-induced thrombocytopenia/thrombosis recognize different epitopes on heparin: platelet factor 4. Blood 91:916-922, 1998
52. Ziporen L, Li ZQ, Park KS, Sabnekar P, Liu WY, Arepally G, Shoenfeld Y, Kieber-Emmons T, Cines DB, Poncz M: Defining an antigenic epitope on platelet factor 4 associated with heparin-induced thrombocytopenia. Blood 92:3250-3259, 1998
53. Li ZQ, Liu W, Park KS, Sachais BS, Arepally GM, Cines DB, Poncz M: Defining a second epitope for heparin-induced thrombocytopenia/thrombosis antibodies using KKO, a murine HIT-like monoclonal antibody. Blood 99:1230-1236, 2002
54. Warkentin TE, Hayward CP, Boshkov LK, Santos AV, Sheppard JA, Bode AP, Kelton JG: Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia. Blood 84:3691-3699, 1994
55. Cines DB, Tomaski A, Tannenbaum S: Immune endothelial-cell injury in heparin-associated thrombocytopenia. N Engl J Med 316:581-589, 1987
56. Blank M, Shoenfeld Y, Tavor S, Praprotnik S, Boffa MC, Weksler B, Walenga MJ, Amiral J, Eldor A: Anti-platelet factor 4/heparin antibodies from patients with heparin-induced thrombocytopenia provoke direct activation of microvascular endothelial cells. Int Immunol 14:121-129, 2002
57. Khairy M, Lasne D, Brohard-Bohn B, Aiach M, Rendu F, Bachelot-Loza C: A new approach in the study of the molecular and cellular events implicated in heparin-induced thrombocytopenia. Formation of leukocyte-platelet aggregates. Thromb Haemost 85:1090-1096, 2001
58. Pouplard C, Iochmann S, Renard B, Herault O, Colombat P, Amiral J, Gruel Y: Induction of monocyte tissue factor expression by antibodies to heparin-platelet factor 4 complexes developed in heparin-induced thrombocytopenia. Blood 97:3300-3302, 2001
59. Arepally GM, Mayer IM: Antibodies from patients with heparin-induced thrombocytopenia stimulate monocytic cells to express tissue factor and secrete interleukin-8. Blood 98:1252-1254, 2001
60. Amiral J, Marfaing-Koka A, Wolf M, Alessi MC, Tardy B, Boyer-Neumann C, Vissac AM, Fressinaud E, Poncz M, Meyer D: Presence of autoantibodies to interleukin-8 or neutrophil-activating peptide-2 in patients with heparin-associated thrombocytopenia. Blood 88:410-416, 1996